Login
Toggle navigation
Videos
Categories
Trending
Getting Ahead of What Comes Next |Natalie Sandman,General Partner,Spark Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Natalie Sandman is the General Partner, Early at Spark Capital.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Jonathan Nelson on Media, Technology, and Business Leadership in Today's Landscape | Jonathan Nelson, CEO, Providence Equity Partners.
00:10:00
Key Vendors in Managing a 401(k) Plan
00:10:00
Silverstorm Mining: High-Grade Drilling Results and Strategic Focus on Production
00:10:00
Expert Discusses Skin Cancer Screenings and Free Diagnostic Testing Opportunities on Sonoran Living |Derek J Maetzold, CEO, Castle Biosciences Inc.
00:10:00
Growing and Connecting Authentically|Romeen Sheth, partner,S & R Angel Fund
00:10:00
Continental Gold: Pioneering Modern-Day Large-Scale Gold Mining in Colombia
00:10:00
Abel Travis, VP & Head of Fundamental Underwriters at AF Group, emphasizes that innovation cannot thrive in isolation..|Amund Tøftum is CEO in AF Gruppen
00:10:00
Nova Minerals CEO Christopher Gettyson Discusses Estelle Gold Project's Growth and Future Plans
00:10:00
Invests in breakthrough scientific startups|Dakin Sloss, General Partner,Prime Movers Lab
00:10:00
Jonathan Stano Discusses Social Security Planning on Fintrust In Focus
00:10:00
Steve Beard on Adtalem's Q4 Earnings, Labor Challenges, and Election Impact | Steve Beard , CEO, Adtalem Global Education.
00:10:00
Vantea Smart’s Successful Market Debut and Focus on Cybersecurity | Simone Veglioni, CEO , Vantea Smart SPA.